Johns Hopkins Diabetes Guide
Niacin
INDICATIONS
FDA
FDA
- Hyperlipidemia
- Adjunct therapy for hypertriglyceridemia
- Pellagra (off-label use)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 4, 2019
Citation
Patel, Nisha K, et al. "Niacin." Johns Hopkins Diabetes Guide, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547098/all/Niacin.
Patel NK, Elder S, Margolis S. Niacin. Johns Hopkins Diabetes Guide. 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547098/all/Niacin. Accessed September 25, 2023.
Patel, N. K., Elder, S., & Margolis, S. (2019). Niacin. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547098/all/Niacin
Patel NK, Elder S, Margolis S. Niacin [Internet]. In: Johns Hopkins Diabetes Guide. ; 2019. [cited 2023 September 25]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547098/all/Niacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Niacin
ID - 547098
A1 - Patel,Nisha,Pharm.D.
AU - Elder,Stacy,Pharm.D., BCP
AU - Margolis,Simeon,M.D.
Y1 - 2019/06/04/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547098/all/Niacin
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
